Complement Regulation to Undo Systemic Harm in Preeclampsia

NCT04725812 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped PI moved institutions

Conditions

Preeclampsia
Severe Preeclampsia
Eculizumab
HELLP
HELLP Syndrome
HELLP Syndrome Second Trimester
Pregnancy Related
AHUS
PNH
Complement Regulatory Factor Defect
Complement Abnormality
HELLP Syndrome Third Trimester

Interventions

DRUG: Eculizumab

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]